This trial is evaluating whether Sleep Coach App will improve 3 primary outcomes and 1 secondary outcome in patients with Sleeplessness. Measurement will happen over the course of baseline to 7 weeks.
This trial requires 30 total participants across 2 different treatment groups
This trial involves 2 different treatments. Sleep Coach App is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
The most frequent symptoms of insomnia are: insomnia, difficulty concentrating, and depressed mood. Insomnia may be related to a poor quality of life and may be an indicator of underlying psychiatric disorders, so it is important to understand that insomnia symptomatology is a common symptom that can be associated with a whole range of other psychiatric disorders. Insomnia is frequently misdiagnosed and therefore the treatment of sleeplessness could have beneficial effects for patient's mental health.
Estimates of sleep disordered breathing are unreliable and inaccurate. They are heavily skewed towards men due to the prevalence and prevalence of sleep disordered breathing (a significant factor is that female patients are less likely to seek counseling regarding such a problem than male patients). While the incidence of sleep disordered breathing is declining in women, the percentage of men who have sleep disordered breathing is increasing due to the aging of the population. Thus, the overall percentage of patients with sleep disordered breathing will continue to rise. Sleep-disordered breathing causes a large number of health complaints that are unrecognized. Improving the understanding of sleep disordered breathing among healthcare providers presents a major opportunity for improved patient care.
Many studies have been done and not all have yielded positive results. A placebo was prescribed for all patients and was monitored for side effect on the night the patient slept. The placebo group was monitored and found to have a shorter sleep duration and duration of quiet sleep compared with the placebo group.
Insomnia can be treated by medications that may improve sleep and in many cases, worsen the sleep. Patients often complain that these medications cause side-effects. Patient education and training can help to reduce some of these issues. As with almost all medications, the risks outweigh the benefits of some drugs for sleepiness, including the risk of heart disease and increased vulnerability to falls. Other common treatments for insomnia are cognitive behavioral therapy (CBT) and relaxation techniques. There is no cure for insomnia, but treatment options are targeted more towards improving sleep quality.
Sleep disturbances are common among adults in the US, with 7 percent reporting sleeping less than 5 hours and 34 percent reporting sleeping less than 7 hours nightly. Most sleep disturbance occurs as a consequence of insomnia. Individuals with sleep problems appear to be at a higher risk of developing or worsening depression.
There is a lack of clarity on the question of the cause of sleeplessness. The common suggestion of insufficient sleep and the idea that sleep deprivation increases risk of illness, injury, or mental health issues are neither correct or plausible for most cases of sleeplessness. Our approach to sleeplessness is to first exclude known, treatable causes and, where that cannot be done, try to identify and treat the underlying cause of sleeplessness in order to reduce risk in the long term.
In this review article, the latest research about the topic was described. The available data on the subject suggests that people who routinely get 3 or more hours of sleep each night have increased cortisol secretion, leading to a range of physiological effects. Atypical sleep pattern is evident among people who report short sleep duration or short sleep duration with daytime naps. The review concludes by stating that the research indicates that an improved sleep pattern seems to have a positive influence on a person's overall well-being. However, poor sleep in older people can be related to psychiatric problems such as depression, and for this reason, sleep hygiene remains of major importance for many elderly citizens.
There is very little evidence to support the effectiveness of a number of alternative'sleep medications'. There are no convincing studies available to show that certain products with the claim to treat sleeplessness are helpful, and may cause harm by overstimulating the body's systems involved in sleep regulation.
In men and women of all age groups, a high percentage of people with unexplained sleeplessness say that they do not use or rely on the most common known reasons for sleep debt. In men and women of all age groups, the following are the most common: work factors, unhealthy sleep hygiene, stress and worry, sleep interruptions, and physical problems. In a recent study, findings highlight the need to more closely examine the psychological and social causes of sleeplessness.
The current study showed that a sleep coach app is effective in the improvement of sleepiness. More well-designed and bigger sample studies are necessary to validate the current findings.
A self-administered, patient-rated, 8-week, prospective study assessed the impact of SleepCoach on sleep, QoL, and physical health. The SleepCoach app was well received. QoL and sleep improved after 6 weeks of use, but changes in the QoL questionnaire did not reach statistical significance. Sleep coach is currently being studied in a larger trial. Clinicians may consider it for patients with sleep complaints.
A small number of patients who have tried all available treatment options for sleeplessness still experience sleep difficulties and should consider clinical trials for treatments to treat this disabling symptom. In the United States, [Federal National Institute of Neurological Disorders and Stroke (NINDS)] conducts research to develop treatments for sleep disorders, including sleep apnea hypopnea, restless leg syndrome, narcolepsy, and insomnia, and other sleep conditions such as restless legs syndrome. These trials compare different therapeutic treatments in patients with sleep disorders. They are [conducted at] [the NIH Clinical Center, National Institutes of Health, Bethesda, Maryland] (https://clinicaltrials.gov/).